BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12458897)

  • 1. A tumor lysis-like syndrome during therapy of visceral leishmaniasis.
    Liberopoulos E; Alexandridis G; Elisaf M
    Ann Clin Lab Sci; 2002; 32(4):419-21. PubMed ID: 12458897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis syndrome during therapy of visceral leishmaniasis.
    Liberopoulos EN; Kei AA; Elisaf MS
    Infection; 2012 Apr; 40(2):121-3. PubMed ID: 22005934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.
    Colakoglu M; Fidan Yaylali G; Yalcin Colakoglu N; Yilmaz M
    Scand J Infect Dis; 2006; 38(3):208-10. PubMed ID: 16500783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report].
    He H; Li C; Han M
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):310-2. PubMed ID: 11721390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor lysis syndrome].
    Jeddi R; Ben Abdennebi Y; Allani B; Belakhal R; Aissaoui L; Ben Abid H; Ali ZB; Meddeb B
    Tunis Med; 2007 Feb; 85(2):174-6. PubMed ID: 17665670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.
    Colakoglu M; Yaylali GF; Colakoglu NY; Yilmaz M
    Scand J Infect Dis; 2006; 38(2):152-4. PubMed ID: 16449014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.
    Meyerhoff A
    Clin Infect Dis; 1999 Jan; 28(1):42-8; discussion 49-51. PubMed ID: 10028069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency care: the tumor lysis syndrome.
    Turtureanu-Hanganu E
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(4):705-11. PubMed ID: 14974215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study.
    Sundar S; Jha TK; Thakur CP; Mishra M; Singh VP; Buffels R
    Clin Infect Dis; 2003 Sep; 37(6):800-4. PubMed ID: 12955641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.
    Sundar S; Mehta H; Suresh AV; Singh SP; Rai M; Murray HW
    Clin Infect Dis; 2004 Feb; 38(3):377-83. PubMed ID: 14727208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.
    Mughal TI; Ejaz AA; Foringer JR; Coiffier B
    Cancer Treat Rev; 2010 Apr; 36(2):164-76. PubMed ID: 20031331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].
    Minodier P; Robert S; Noël G; Blanc P; Retornaz K; Garnier JM
    Arch Pediatr; 2005 Jul; 12(7):1102-8. PubMed ID: 15964525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of visceral leishmaniasis with liposomal amphotericin B.
    Lagler H; Matt U; Sillaber C; Winkler S; Graninger W
    Acta Biomed; 2006; 77 Suppl 2():22-5. PubMed ID: 16918063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of tumor lysis syndrome with the highest known uric acid level.
    Ozkan G; Ulusoy S; Sönmez M; Kaynar K; Karagülle M
    Ren Fail; 2010; 32(7):895-8. PubMed ID: 20662707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatorenal syndrome after treatment of visceral leishmaniasis requiring terlipressin therapy.
    Marzano A; Debernardi Venon W; Sacco M; Rizzetto M
    Minerva Gastroenterol Dietol; 2015 Sep; 61(3):171-2. PubMed ID: 26161570
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of tumor lysis syndrome.
    Rampello E; Fricia T; Malaguarnera M
    Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor lysis syndrome.
    Arrambide K; Toto RD
    Semin Nephrol; 1993 May; 13(3):273-80. PubMed ID: 8321927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B.
    Beltrame A; Arzese A; Camporese A; Rorato G; Crapis M; Tarabini-Castellani G; Boscutti G; Pizzolitto S; Calianno G; Matteelli A; Di Muccio T; Gramiccia M; Viale P
    J Travel Med; 2008; 15(5):358-60. PubMed ID: 19006511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan.
    Mueller M; Balasegaram M; Koummuki Y; Ritmeijer K; Santana MR; Davidson R
    J Antimicrob Chemother; 2006 Oct; 58(4):811-5. PubMed ID: 16916865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.